Literature DB >> 18523772

MHC-dependent desensitization of intrinsic anti-self reactivity.

Cristan M Jubala1, Angela R Lamerato-Kozicki, Michelle Borakove, Julie Lang, Lori A Gardner, David Coffey, Karen M Helm, Jerome Schaack, Monika Baier, Gary R Cutter, Donald Bellgrau, Jaime F Modiano.   

Abstract

The survival of naive T cells is compromised in the absence of molecules encoded by the major histocompatibility complex (MHC) while antigen-experienced T cells survive. We hypothesized that survival pressures in an in vivo, MHC-deficient environment would permit enrichment of less frequent antigen-experienced autoreactive cells at the expense of the majority of antigen naive T cells. To test this hypothesis, we generated MHC class I- and class II-deficient mice in NOD and C57Bl/6 (B6) backgrounds, and examined the capacity of adoptively transferred autoimmune-prone NOD T cells, or non-autoimmune prone naive B6 T cells, respectively, to reject transplanted wild-type pancreatic islets or transplantable tumors in the MHC-deficient mice. In the MHC-deficient environment, CD4 T cells acquired self-hostile properties (islet rejection and tumor invasion) that were independent from their genetic propensity for autoreactivity, while CD8 T cells required appropriate prior exposure to antigen in order to survive and function (reject tumor) in this environment; however, disengagement of Tob1, a negative regulator of proliferation, led to a reverse phenotype with regard to persistence of CD4 and CD8 T cells in the MHC-deficient environment. Our data suggest that self-peptide/MHC interactions have dual roles to facilitate survival and restrain autoreactivity, thus acting as integral components of an intrinsic network of negative regulation that maintains tolerance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18523772      PMCID: PMC2585149          DOI: 10.1007/s00262-008-0535-0

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  68 in total

Review 1.  MHC and T cell development.

Authors:  C Viret; C A Janeway
Journal:  Rev Immunogenet       Date:  1999

2.  Quiescent T cells: actively maintaining inactivity.

Authors:  X Hua; C B Thompson
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

3.  Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway.

Authors:  A F Buckley; C T Kuo; J M Leiden
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

4.  Tetracycline-controllable selection of CD4(+) T cells: half-life and survival signals in the absence of major histocompatibility complex class II molecules.

Authors:  D Witherden; N van Oers; C Waltzinger; A Weiss; C Benoist; D Mathis
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

5.  MHC class II deprivation impairs CD4 T cell motility and responsiveness to antigen-bearing dendritic cells in vivo.

Authors:  Ursula B Fischer; Erica L Jacovetty; Ricardo B Medeiros; Brian D Goudy; Traci Zell; Jeannie-Beth Swanson; Elizabeth Lorenz; Yoji Shimizu; Mark J Miller; Alexander Khoruts; Elizabeth Ingulli
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-13       Impact factor: 11.205

Review 6.  Cytokines and T-cell homeostasis.

Authors:  Onur Boyman; Jared F Purton; Charles D Surh; Jonathan Sprent
Journal:  Curr Opin Immunol       Date:  2007-04-12       Impact factor: 7.486

7.  IL-15 is required for sustained lymphopenia-driven proliferation and accumulation of CD8 T cells.

Authors:  Michelle M Sandau; Colleen J Winstead; Stephen C Jameson
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

8.  Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells.

Authors:  D Tzachanis; G J Freeman; N Hirano; A A van Puijenbroek; M W Delfs; A Berezovskaya; L M Nadler; V A Boussiotis
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

9.  Alpha beta TCR+ cells are a minimal fraction of peripheral CD8+ pool in MHC class I-deficient mice.

Authors:  D Nesić; F R Santori; S Vukmanović
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

10.  CDK4 expression and activity are required for cytokine responsiveness in T cells.

Authors:  J F Modiano; J Mayor; C Ball; M K Fuentes; D S Linthicum
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

View more
  4 in total

1.  Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment.

Authors:  Jaime F Modiano; Beth A Lindborg; Ron T McElmurry; Mitzi Lewellen; Colleen L Forster; Edward A Zamora; Jerome Schaack; Donald Bellgrau; Timothy D O'Brien; Jakub Tolar
Journal:  Cancer Immunol Immunother       Date:  2015-08-07       Impact factor: 6.968

Review 2.  Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells.

Authors:  Jonathan Sprent; Charles D Surh
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

3.  Inflammation, apoptosis, and necrosis induced by neoadjuvant fas ligand gene therapy improves survival of dogs with spontaneous bone cancer.

Authors:  Jaime F Modiano; Donald Bellgrau; Gary R Cutter; Susan E Lana; Nicole P Ehrhart; Ej Ehrhart; Vicki L Wilke; J Brad Charles; Sibyl Munson; Milcah C Scott; John Pozniak; Cathy S Carlson; Jerome Schaack; Richard C Duke
Journal:  Mol Ther       Date:  2012-07-31       Impact factor: 11.454

4.  Nfatc2 and Tob1 have non-overlapping function in T cell negative regulation and tumorigenesis.

Authors:  Sarah L May; Qing Zhou; Mitzi Lewellen; Cristan M Carter; David Coffey; Steven L Highfill; Christoph M Bucher; Ilze Matise; Herbert C Morse; M Gerard O'Sullivan; Melissa Schutten; Charles Johnson; Donald Bellgrau; Bruce R Blazar; Jaime F Modiano
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.